Jd. Stewart et al., PLACEBO-CONTROLLED COMPARISON BETWEEN A SINGLE-DOSE AND A MULTIDOSE OF BETAMETHASONE IN ACCELERATING LUNG MATURATION OF MICE OFFSPRING, American journal of obstetrics and gynecology, 179(5), 1998, pp. 1241-1247
OBJECTIVE: Our purpose was to determine, in a placebo-controlled manne
r with a mouse model, whether a multidose of betamethasone is more ben
eficial than a single dose in accelerating fetal lung maturation. STUD
Y DESIGN: Ninety gravid CD-1 mice were randomly assigned to 1 of 3 gro
ups (n = 30) to receive either a placebo (0.25 mL subcutaneously) or b
etamethasone (0.1 mg subcutaneously) as a single dose on gestational d
ay 14 or as a multidose twice daily on gestational day 14 and 15. Ten
pregnancies in each group were terminated at gestational day 16.5 to o
bserve the neonatal breathing pattern (scale 0 to 5; 5 is unlabored br
eathing) and the lung histologic findings (scale 0 to 5; 5 is alveolar
budding). The lungs of the offspring belonging to the remaining 20 pr
egnancies in each group were removed and weighed at postnatal day 1, 3
, 5, or 120. RESULTS: Fetuses exposed to a multidose of betamethasone
displayed a higher breathing score at gestational day 16.5 than either
to a single dose or to the placebo (mean score 4.6 vs 3.8 or 1.3, P <
.001). Alveolar development was greater after exposure to a multidose
of betamethasone than after a single dose or after a placebo (mean sc
ore 4.4 vs 3.5 or 1.6; P < .001). The lung weights at gestational day
16.5 were less after a multidose of betamethasone than after a single
dose of either betamethasone or a placebo (18.3 +/- 1.0 g vs 21.4 +/-
1.3 g or 23.3 +/- 1.3 g; P < .02). The lung/body weight ratio was simi
larly affected. This reduced weight of the lungs persisted postnatally
into adulthood. CONCLUSIONS: With a CD-I mouse model, a multidose of
antenatal betamethasone accelerated fetal lung maturation more than af
ter a single dose but was accompanied with a decrease in lung weight t
hat persisted into adulthood.